CVR 45192903Private limited company (ApS)Anden udgivelse af software (582900)København KFounded 6 Nov 2024
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about PharosBio ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
1
CVR, Aug 2026
-1 (-50%) over 12 months
Gross profit
44.2K
DKK, annual report 2025
Result
-318.7K
DKK, annual report 2025
Equity
839.2K
DKK, annual report 2025
Bogumil Zimon ApSCVR 45178161, 66.7% to under 90% of capital and votes, since 6 Nov 2024
Antler Nordic Fund II AB10% to under 15% of capital and votes, since 2 Dec 2024
and 1 moreOperating company
Dandex estimate: 1 employee registered in 2026Bogumil Zimonsince 6 Nov 2024
CVR 398657695% to under 10% of capital and votesnotified 2 Dec 2024since 6 Nov 2024
CVR 4517816166.7% to under 90% of capital and votesnotified 23 Oct 2026since 6 Nov 2024
10% to under 15% of capital and votessince 2 Dec 2024
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR 4517981833.3% to under 50% of capital and votesnotified 23 Oct 20266 Nov 2024 to 23 Oct 2026
Ultimate controller
Holds 100% of capital and votes in Bogumil Zimon ApS, since 31 Oct 2024
Holding company
CVR 45178161Private limited company (ApS)
Holds 66.7% to under 90% of capital and votes in PharosBio ApS, since 6 Nov 2024
This company
PharosBio ApS
CVR 45192903
Decided by Dandex with fixed rules from CVR and the filed annual reports, and for the auditor's report, the business model and the revenue model a calibrated decision model reading the report's text and the purpose clause, not registered by the company. Each label links to its definition.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
Aug 2026, monthly: 1 employee, 1 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Dec 2024 | Jan 2025 | Feb 2025 | Mar 2025 | Apr 2025 | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 |
| FTE | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's own headcount as CVR records it, not the annual report's average, which may cover a group. Monthly Dec 2024 to Aug 2026.
Latest Aug 2026, published 21 Oct 2026. Source: CVR employment series (Årsbeskæftigelse, Kvartalsbeskæftigelse, Månedsbeskæftigelse).
| Metric | 2025 |
|---|---|
| Gross profit | 44 |
| Operating profit | -402 |
| Result for the year | -319 |
| Equity | 839 |
| Total assets | 924 |
| Employees (average) | 2 |
| Credit metrics (Dandex calculations) | |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. |
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. |
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. |
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. |
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. |
| Capex (investeringer i anlægsaktiver) | 394note 1 |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. |
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group. 2025 covers 14 months (6 Nov 2024 to 31 Dec 2025).
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages. Gearing and interest coverage are multiples. Rows marked Pro hold a value in the Pro plan. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
Annual report 2025
6 Nov 2024 to 31 Dec 2025, published 11 Jun 2026
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The rows marked Pro on this page hold values in the Pro plan. For PharosBio ApS, that is:
Have Pro? Sign in to see the values on this page.
Each registered value from the day it took effect, newest first.
From CVR, read 16 Nov 2026. Text such as the signing rule and purpose is shown as registered.
From CVR, read 16 Nov 2026. A change is counted each time the registry records a new value, so a corrected address or an audit firm under a new entity counts too.
4 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Vedtægter ændret: 23.10.2026
Direktion:
Fratrådte:
Aurél György Prósz, den 23.10.2026.
Selskabet tegnes af en direktør.
Ny adresse: Bryghuspladsen 8, 1473 København K
Vedtægter ændret: 02.12.2024
Kapitalforhøjelsen er besluttet den 02.12.2024.
kr. 5.048,00, indbetalt kontant, kurs 22.136,02.
Kapitalen udgør herefter kr. 45.483,00.
Stiftelsesdato: 06.11.2024.
Virkningsdato: 06.11.2024.
Seneste vedtægtsdato: 06.11.2024.
Kapital:
kr. 40.435,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 40.435,00 til kurs 100,00, fuldt indbetalt.
Stiftere:
CVR-NR. 45178161 Bogumil Zimon ApS, c/o Bogumil Zimon, Strandlodsvej 11M, 6. th, 2300 København S, den 06.11.2024, CVR-NR. 45179818 Aurel Prosz ApS, c/o Aurel Prosz, Skovbrynet 2F, 1. 4, 2800 Kongens Lyngby, den 06.11.2024.
Direktion:
Aurél György Prósz, den 06.11.2024, Bogumil Zimon, den 06.11.2024.
Selskabet tegnes af to direktører i forening.
Første regnskabsår:
06.11.2024 - 31.12.2025.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er at udvikle en softwareplatform, der accelerer videnskabelige opdagelser i life science-virksomheder gennem integration af eksperimentelle resultater og publikationer samt at udføre hermed beslægtede virksomhedsaktiviteter.
1 registered in CVR.
P-number 1030815250Bryghuspladsen 8, 1473 København K